MDCN Stock UPDATES Medican Enterprises Inc. (MDCN) 0.5800 09/22/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medican Enterprises Inc. (MDCN) 0.5800 $MDCN

Medican Moves toward Closing the Purchase of 51% of International Herbs Medical Marijuana Ltd. (IHMML)
Business Wire - Mon Sep 08, 7:01AM CDT
Medican Enterprises, Inc. (OTCBB:MDCN), a bio-pharmaceutical company focused on manufacturing and selling pharmaceutical grade cannabis in Canada, continues to update the public on its acquisition of a 51% interest in International Herbs Medical Marijuana Ltd. (IHMML).

Medican Enters into Letter of Intent to Restructure Its Proposed Acquisition of Canadian Medical Marijuana Business
Business Wire - Wed Jul 30, 11:00AM CDT
--Transaction would also shift majority ownership and control of Medicanto IHMML and its affiliates

Medican Director Assumes New Leadership Position as CEO of Cannabis Sativa Inc.
Business Wire - Mon Jul 07, 7:00AM CDT
Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce its director, Gary Johnson, was recently appointed CEO of Cannabis Sativa Inc. (OTCQB:CBDS).

Medican is in Negotiations to Obtain 51% of IHMML
Business Wire - Mon Jun 30, 6:30AM CDT
Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd ("IHMML" . Medican previously announced that they signed an agreement to obtain 50% of IHMML, but for consolidation purposes and increasing role undertaken by the IHMML management team, we are finalizing terms for a 51% acquisition. This will give Medican a controlling interest in IHMML and fits in well with our long-term vision to become a leader in the medical marijuana space.

A Closer Look at Enertopia's Three MMJ Projects
ACCESSWIRE - Mon Jun 23, 8:40AM CDT
WHITEFISH, MT / June 23, 2014 / Canada's Marijuana for Medical Purposes Regulations ("MMPR" has attracted a lot of investor interest, as evidenced by Tweed Marijuana Inc.'s (TSX-V: TWD) (OTC: TWMJF) nearly $100 million market capitalization. Health Canada estimates that the market for legalized marijuana could surpass $1.3 billion with 450,000 patients over the next ten years, while adult use legalization could eventually add to the total.

CannabisFN Weekly: Cannabis Sector Gears Up for Canada's MMPR
ACCESSWIRE - Mon Mar 31, 8:01AM CDT
Whitefish, MT / March 31, 2014 / The Marijuana Index™ moved lower over the past week due in large part to a 40% drop in shares of Cannavest Corp. (OTCBB: CANV) along with broader declines across the sector. Many traders appeared to be locking in profits after a volatile start to 2014 although cannabis stocks showed signs of recovery during Friday's session and long-term industry catalysts like regulatory reform remain very intact.

Medican Enterprises Engages TDM Financial for Investor Communication & Marketing
ACCESSWIRE - Mon Mar 31, 7:22AM CDT
WHITEFISH, MT / ACCESSWIRE / March 31, 2014 / TDM Financial, a leading financial network covering new, emerging and established companies across many different industry verticals, today announced that Medican Enterprises, Inc. (OTCBB: MDCN) has engaged its services. Medican Enterprises is a biopharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market.

Canadian National Medical Marihuana Association Welcomes Three New Industry Members
CNW Group - Fri Mar 28, 1:49PM CDT
The Canadian National Medical Marihuana Association (CNMMA) is pleased to announce Dyma Inc., Medican Enterprises, and Zenabis as its newest members.

Medican Systems Signs LOI to Acquire 50% Stake in International Herbs Medical Marijuana Ltd.
Business Wire - Wed Mar 26, 10:58AM CDT
Medican Enterprises, Inc. (OTCBB: MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its wholly owned subsidiary Medican Systems Inc. has signed a letter of intent (LOI) to purchase 50% of International Herbs Medical Marijuana Ltd. ("IHMML" . IHMML has applied as a licensed producer under the Health Canada, Marijuana for Medical Purposes Regulations program.

Medican Enterprises enters into Management Services agreement with International Herbs and LFG Advisory & Accounting
M2 - Wed Mar 19, 7:26AM CDT
Medican Enterprises Inc (OTCBB:MDCN), a bio-pharmaceutical company focused on pharmaceutical grade cannabis for the medical marijuana market, announced on Tuesday that the company and its subsidiaries, Medican Systems Inc and Medican (CanaLeaf) Systems Inc, have entered into an amended management service agreement with International Herbs Ltd (IHL), a fresh herbs and specialty produce company, and LFG Advisory & Accounting Ltd (LFG), an independent corporate finance and accounting advisory firm, or the consultants, effective 13 March 2014.

Medican Enterprises Signs Management Services Agreement
Business Wire - Tue Mar 18, 7:01AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) ("Medican," "the Company" , is pleased to announce the company and its subsidiaries Medican Systems Inc. and Medican (CanaLeaf) Systems Inc. have entered into an Amended Management Service Agreement with International Herbs Ltd ("IHL" and LFG Advisory & Accounting Ltd. ("LFG" or the Consultants, effective March 13, 2014.

Medican Enterprises names David Tobias to Advisory Board
M2 - Tue Mar 18, 4:21AM CDT
Bio-pharmaceutical company Medican Enterprises Inc (OTCBB: MDCN) announced on Monday that it has appointed David Tobias to the company's advisory board, effective 3 March 2014.

Industry Veteran David Tobias Joins Medican Enterprises Advisory Board
Business Wire - Mon Mar 17, 7:00AM CDT
Medican Enterprises, Inc. (OTCBB: MDCN) a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce the appointment of David Tobias to the Company's advisory board, effective March 3, 2014.

Medican Enterprises names former New Mexico Governor Gary Johnson to the board
M2 - Thu Mar 13, 7:28AM CDT
Bio-pharmaceutical company Medican Enterprises (OTC BB:MDCN) revealed on Wednesday Gary Johnson's appointment to its board of directors effective 23 January 2014.

Medican names Gary Johnson to board
M2 - Thu Mar 13, 5:26AM CDT
Medican Enterprises Inc (OTCBB:MDCN), a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the medical marijuana market, announced on Wednesday the appointment of Gary Johnson to its board of directors, effective 23 January 2014.

Medican Enterprises Inc. Appoints Former New Mexico Governor to the Board of Directors
Business Wire - Wed Mar 12, 7:00AM CDT
Medican Enterprises Inc. (OTCBB:MDCN) a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market is pleased to announce it has appointed Gary Johnson, a former two-term Republican governor of New Mexico, to its Board of Directors, effective January 23, 2014.

Medican Enterprises names Wayne Hansen as its new CFO
M2 - Fri Mar 07, 5:01AM CST
Medican Enterprises Inc (OTCBB:MDCN), a biopharmaceutical company providing pharmaceutical grade cannabis, announced on Thursday that it has appointed Wayne Hansen as chief financial officer of the company, effective 19 February 2014.

Medican Enterprises Appoints Wayne Hansen as CFO
Business Wire - Thu Mar 06, 7:02AM CST
Medican Enterprises Inc. (OTCBB: MDCN), a leading developer, distributor and marketer of pharmaceutical grade cannabis, is pleased to announce the appointment of Wayne Hansen to the position Chief Financial Officer, effective February 19, 2014.

Some Penny Stocks Reinvent Themselves While Others Remain Silent: Cre8tive Works, Inc. (OTCPINK: RANFD), Medican Enterprises Inc. (OTCQB: MDCN), Voltaire Corp. (OTCQB: VLTCW), Harbor Bankshares Corp. (OTCQB: HRBK)
ACCESSWIRE - Mon Feb 10, 10:09AM CST
If you follow the realm of penny stocks closely, then you know every day there are dramas and intrigues being played out in press releases, government filings and through the daily gyrations of share volume and prices.

Possible Entry into Medical Marijuana and Reinvention Spark Penny Stock Shares
ACCESSWIRE - Mon Jan 27, 7:15AM CST
The reinvention of several penny stock companies and the potential entry of one of them into the medical marijuana business are factors boosting their share values.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 147

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 143

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 303

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 185

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 292

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 146

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

Heights Wellness Retreat: A Bold Step Towards Holistic Wellness

Updated Category News Views 227

Heights Wellness Retreat: A New Era of Wellness In a landmark announcement during their annual summit, Massage Heights unveiled a significant transformation that redefines their brand identity. The brand, known for its commitment to wellness over the past two decades, will now operate under the name Heights Wellness Retreat. This evolution is more than just a new name; it...

Continue Reading
GeneDx Strengthens Leadership with New COO Appointment

Updated Category News Views 168

GeneDx Welcomes Bryan Dechairo as Chief Operating Officer GeneDx (NASDAQ: WGS) has made headlines with the appointment of Bryan Dechairo as its new Chief Operating Officer. This strategic decision aims to enhance operations and drive the company’s next phase of growth. Enhancing Operations for Future Success As COO, Dechairo will oversee critical areas including Product...

Continue Reading
FreightCar America to Share Q1 2025 Financial Results Soon

Updated Category News Views 130

FreightCar America Prepares for Q1 2025 Earnings Announcement FreightCar America, Inc. (NASDAQ: RAIL), a prominent player in the manufacturing of railroad freight cars, is gearing up to release its financial results for the first quarter of 2025. This important announcement is scheduled for after the market closes on a Monday, allowing investors and stakeholders to digest...

Continue Reading
Empowering Veterans: United Food Group's New Initiative

Updated Category News Views 129

United Food Group Unveils New Employment Initiative United Food Group, a noted developer and manufacturer of coffee equipment, powdered condiments, and beverages, has announced an innovative employment initiative designed to support wounded veterans and first responders. This program not only aims to empower these individuals but also provides them with specialized...

Continue Reading
US Futures Gain on Peace Talk Hopes Amid Market Developments

Updated Category News Views 206

U.S. Stock Futures Trend Upward U.S. stock futures saw an increase following the extended weekend, coming off a mixed trading day last Friday. The day off for Presidents Day allowed investors to reassess their positions. As a result, all four major indices posted gains in premarket trading. Investor Focus on Macro Conditions In today's trading, investors will closely...

Continue Reading